UBS downgraded Ambev (ABEV) to Neutral from Buy with a R$16 price target Given the 20% year-to-date return, the analyst sees a more balanced risk/reward at current levels.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEV:
- Ambev S.A. Expands Shareholdings with Significant Purchases in March 2025
- Ambev S.A. Reports March 2025 Securities Transactions
- Ambev downgraded to Underweight from Equal Weight at Morgan Stanley
- Ambev price target raised to $2.45 from $2.20 at BofA
- Ambev S.A. Files April 2024 SEC Report Detailing Corporate and Securities Information